Linkage Analysis of Genomic Regions Contributing to the Expression of Type 1 Diabetes Microvascular Complications and Interaction with HLA

Ettie M. Lipner, Yaron Tomer, Janelle A. Noble, Maria C. Monti, John T. Lonsdale, Barbara Corso, David A. Greenberg

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We conducted linkage analysis to follow up earlier work on microvascular complications of type 1 diabetes (T1D). We analyzed 415 families (2,008 individuals) previously genotyped for 402 SNP markers spanning chromosome 6. We did linkage analysis for the phenotypes of retinopathy and nephropathy. For retinopathy, two linkage peaks were mapped: one located at the HLA region and another novel locus telomeric to HLA. For nephropathy, a linkage peak centromeric to HLA was mapped, but the linkage peak telomeric to HLA seen in retinopathy was absent. Because of the strong association of T1D with DRB103:01 and DRB104:01, we stratified our analyses based on families whose probands were positive for DRB103:01 or DRB104:01. When analyzing the DRB103:01-positive retinopathy families, in addition to the novel telomeric locus, one centromeric to HLA was identified at the same location as the nephropathy peak. When we stratified on DRB104:01-positive families, the HLA telomeric peak strengthened but the centromeric peak disappeared. Our findings showed that HLA and non-HLA loci on chromosome 6 are involved in T1D complications' expression. While the HLA region is a major contributor to the expression of T1D, our results suggest an interaction between specific HLA alleles and other loci that influence complications' expression.

Original languageEnglish (US)
Article number694107
JournalJournal of Diabetes Research
Volume2015
DOIs
StatePublished - 2015

Fingerprint

Diabetes Complications
Type 1 Diabetes Mellitus
Chromosomes, Human, Pair 6
Single Nucleotide Polymorphism
Alleles
Phenotype

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Linkage Analysis of Genomic Regions Contributing to the Expression of Type 1 Diabetes Microvascular Complications and Interaction with HLA. / Lipner, Ettie M.; Tomer, Yaron; Noble, Janelle A.; Monti, Maria C.; Lonsdale, John T.; Corso, Barbara; Greenberg, David A.

In: Journal of Diabetes Research, Vol. 2015, 694107, 2015.

Research output: Contribution to journalArticle

Lipner, Ettie M. ; Tomer, Yaron ; Noble, Janelle A. ; Monti, Maria C. ; Lonsdale, John T. ; Corso, Barbara ; Greenberg, David A. / Linkage Analysis of Genomic Regions Contributing to the Expression of Type 1 Diabetes Microvascular Complications and Interaction with HLA. In: Journal of Diabetes Research. 2015 ; Vol. 2015.
@article{da8b086b76ca409884201a6ffcd782db,
title = "Linkage Analysis of Genomic Regions Contributing to the Expression of Type 1 Diabetes Microvascular Complications and Interaction with HLA",
abstract = "We conducted linkage analysis to follow up earlier work on microvascular complications of type 1 diabetes (T1D). We analyzed 415 families (2,008 individuals) previously genotyped for 402 SNP markers spanning chromosome 6. We did linkage analysis for the phenotypes of retinopathy and nephropathy. For retinopathy, two linkage peaks were mapped: one located at the HLA region and another novel locus telomeric to HLA. For nephropathy, a linkage peak centromeric to HLA was mapped, but the linkage peak telomeric to HLA seen in retinopathy was absent. Because of the strong association of T1D with DRB103:01 and DRB104:01, we stratified our analyses based on families whose probands were positive for DRB103:01 or DRB104:01. When analyzing the DRB103:01-positive retinopathy families, in addition to the novel telomeric locus, one centromeric to HLA was identified at the same location as the nephropathy peak. When we stratified on DRB104:01-positive families, the HLA telomeric peak strengthened but the centromeric peak disappeared. Our findings showed that HLA and non-HLA loci on chromosome 6 are involved in T1D complications' expression. While the HLA region is a major contributor to the expression of T1D, our results suggest an interaction between specific HLA alleles and other loci that influence complications' expression.",
author = "Lipner, {Ettie M.} and Yaron Tomer and Noble, {Janelle A.} and Monti, {Maria C.} and Lonsdale, {John T.} and Barbara Corso and Greenberg, {David A.}",
year = "2015",
doi = "10.1155/2015/694107",
language = "English (US)",
volume = "2015",
journal = "Journal of Diabetes Research",
issn = "2314-6745",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Linkage Analysis of Genomic Regions Contributing to the Expression of Type 1 Diabetes Microvascular Complications and Interaction with HLA

AU - Lipner, Ettie M.

AU - Tomer, Yaron

AU - Noble, Janelle A.

AU - Monti, Maria C.

AU - Lonsdale, John T.

AU - Corso, Barbara

AU - Greenberg, David A.

PY - 2015

Y1 - 2015

N2 - We conducted linkage analysis to follow up earlier work on microvascular complications of type 1 diabetes (T1D). We analyzed 415 families (2,008 individuals) previously genotyped for 402 SNP markers spanning chromosome 6. We did linkage analysis for the phenotypes of retinopathy and nephropathy. For retinopathy, two linkage peaks were mapped: one located at the HLA region and another novel locus telomeric to HLA. For nephropathy, a linkage peak centromeric to HLA was mapped, but the linkage peak telomeric to HLA seen in retinopathy was absent. Because of the strong association of T1D with DRB103:01 and DRB104:01, we stratified our analyses based on families whose probands were positive for DRB103:01 or DRB104:01. When analyzing the DRB103:01-positive retinopathy families, in addition to the novel telomeric locus, one centromeric to HLA was identified at the same location as the nephropathy peak. When we stratified on DRB104:01-positive families, the HLA telomeric peak strengthened but the centromeric peak disappeared. Our findings showed that HLA and non-HLA loci on chromosome 6 are involved in T1D complications' expression. While the HLA region is a major contributor to the expression of T1D, our results suggest an interaction between specific HLA alleles and other loci that influence complications' expression.

AB - We conducted linkage analysis to follow up earlier work on microvascular complications of type 1 diabetes (T1D). We analyzed 415 families (2,008 individuals) previously genotyped for 402 SNP markers spanning chromosome 6. We did linkage analysis for the phenotypes of retinopathy and nephropathy. For retinopathy, two linkage peaks were mapped: one located at the HLA region and another novel locus telomeric to HLA. For nephropathy, a linkage peak centromeric to HLA was mapped, but the linkage peak telomeric to HLA seen in retinopathy was absent. Because of the strong association of T1D with DRB103:01 and DRB104:01, we stratified our analyses based on families whose probands were positive for DRB103:01 or DRB104:01. When analyzing the DRB103:01-positive retinopathy families, in addition to the novel telomeric locus, one centromeric to HLA was identified at the same location as the nephropathy peak. When we stratified on DRB104:01-positive families, the HLA telomeric peak strengthened but the centromeric peak disappeared. Our findings showed that HLA and non-HLA loci on chromosome 6 are involved in T1D complications' expression. While the HLA region is a major contributor to the expression of T1D, our results suggest an interaction between specific HLA alleles and other loci that influence complications' expression.

UR - http://www.scopus.com/inward/record.url?scp=84946024974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946024974&partnerID=8YFLogxK

U2 - 10.1155/2015/694107

DO - 10.1155/2015/694107

M3 - Article

VL - 2015

JO - Journal of Diabetes Research

JF - Journal of Diabetes Research

SN - 2314-6745

M1 - 694107

ER -